Tag Archives: hiv
A major announcement scheduled for Tuesday at Western University.
According to a news release, Western University and Sumagen Canada will unveil “preliminary results for the first-ever human applied clinical study of the world’s only preventative HIV vaccine.”
A news conference is set for 11 a.m. Tuesday at Western University.
AM980 will have a reporter on hand for the announcement.
The vaccine made international headlines when Western University’s Dr. Chil-Yong Kang announced in December 2011 his team had received permission from the U.S. Food and Drug Administration to begin clinical trials in humans.
Those trials, involving 40 HIV-positive volunteers, began in March 2012.
Depending on the outcome the vaccine would advance to a second phase which measures “immune responses in humans, involving approximately 600 HIV-negative volunteers who are in the high-risk category for HIV infection.”
The third, and final phase, would measure “the efficacy of the vaccine, involving approximately 6,000 HIV-negative volunteers who are also in the high-risk category for HIV infection.”
Scientists at Western University, financially backed by the pharmaceutical venture company Sumagen, developed the vaccine, which is based on a genetically modified killed whole virus. The vaccine stimulated a strong immune response in early testing and appears to have no adverse effects, according to the researchers.
Daniel Garofali reports on the Red Carpet of the amfAR Inspiration Gala 2012 at the New York Public Library, June 7th 2012.
London, Ontario CANADA –The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.
Developed by Dr. Chil-Yong Kang and his team at The University of Western Ontario, with the support of Sumagen Canada, the vaccine (SAV001) holds tremendous promise, having already proven to stimulate strong immune responses in preliminary toxicology tests with no adverse effects or safety risks. It is the only HIV vaccine currently under development in Canada, and one of only a few in the world.
A: How did finding out you were HIV positive change your life in the beginning? Was that a period in your life you consider to be difficult or a period of growth?
J: Well I found out when I was only 20. I was a junior in college and it was 1989 so there were really no treatments. I assumed I would be dead in about 5 more years. All my friends were dying. Strangely I freaked out for a bit and then I got a good doctor and just went on with life. Even then I didn’t let it define me. I told a few friends and I took care of myself as well as I could. As the treatments got better I got better. Now, it’s been over 22 years and I’ve never been healthier. Statistically I should be dead. I know I’m one of the lucky ones. Reflecting on your mortality is always a period of spiritual and emotional growth. You learn the most about yourself when you have to cope with seemingly insurmountable issues. Now I look back st HIV as a good thing in my life. It has made me a better person. I take batter care of myself and I’m able to do amazing work that has changed people’s lives. Not many people get to say that. I’m grateful.
WHERE CAN YOU GET TESTED? CLICK HERE
Timothy Ray Brown:1st ever fully cured HIV-AIDS patient
Timothy Ray Brown, a resident of San Francisco Bay Area, is possibly the first ever person to be fully cured of the incurable HIV-AIDS disease, according to scientific journal Blood.
Timothy Ray Brown was tested positive for HIV around 15 years ago when he was around the age of 30. He later found out that he was also diagnosed with Leukemia. When he was still in Germany in 2007, doctors used bone marrow stem cell transplant as a method of curing his Leukemia and neither HIV nor Leukemia has been traced on him since 2008.
“I quit taking my HIV medication the day that I got the transplant and haven’t had to take any since,” said Brown, who is known as ‘The Berlin Patient’ in medical circles. [READ MORE via IBTimes]